Medicine and health

Poliomyelitis: Causes, Symptoms, Treatment

Poliomyelitis, commonly known as polio, is a highly infectious viral disease caused by the poliovirus, primarily affecting young children. The disease is characterized by fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. In a small percentage of cases, polio leads to paralysis, which can be permanent. Polio is transmitted through contaminated food and water or through contact with an infected person’s feces. The virus enters the body through the mouth and multiplies in the intestine. From there, it can invade the nervous system, causing paralysis.

The poliovirus is part of the genus Enterovirus, family Picornaviridae. There are three serotypes of the poliovirus: type 1, type 2, and type 3. All three serotypes can cause polio and are spread through the fecal-oral route, meaning they are ingested through contaminated food or water.

In regions where sanitation and hygiene are poor, the virus spreads easily, leading to outbreaks. However, thanks to global vaccination efforts, polio has been eradicated in many parts of the world. The development of the polio vaccine by Jonas Salk in 1955 and Albert Sabin’s oral polio vaccine in the early 1960s marked significant milestones in the fight against the disease.

The symptoms of polio vary depending on the severity of the infection. In its mildest form, polio may cause flu-like symptoms such as fever, sore throat, headache, and vomiting. This is known as abortive polio, and the symptoms usually resolve within a week.

Non-paralytic polio, also known as aseptic meningitis, causes symptoms such as fever, headache, stiff neck, and muscle pain or weakness. These symptoms typically last for 1 to 10 days and resolve completely, with no permanent paralysis.

The most severe form of polio is paralytic polio, which occurs in about 1% of cases. Paralytic polio leads to muscle weakness or paralysis, usually in the legs, though it can also affect the muscles of the arms, neck, and diaphragm. In some cases, paralysis can be permanent, leading to long-term disability.

The diagnosis of polio is based on the patient’s symptoms, physical examination, and laboratory tests. Laboratory tests, such as viral culture or polymerase chain reaction (PCR), can confirm the presence of the poliovirus in samples of stool, throat secretions, or cerebrospinal fluid.

There is no cure for polio, but vaccination is highly effective in preventing the disease. The World Health Organization (WHO) recommends routine vaccination of children with the inactivated polio vaccine (IPV) and the oral polio vaccine (OPV). IPV is given as an injection, while OPV is administered orally.

In areas where polio is endemic or outbreaks occur, mass vaccination campaigns are conducted to ensure high vaccine coverage and interrupt transmission of the virus. These efforts have been successful in reducing the number of polio cases worldwide.

In addition to vaccination, supportive care is essential for patients with polio. This may include rest, pain relief medications, physical therapy, and assistive devices such as braces or wheelchairs for those with paralysis. Respiratory support may be necessary for patients with paralysis of the respiratory muscles.

Despite significant progress in polio eradication efforts, challenges remain. Conflict, insecurity, and vaccine hesitancy in some communities have hindered vaccination campaigns in certain regions. Additionally, the poliovirus can still circulate in areas with inadequate vaccination coverage, leading to outbreaks.

To address these challenges, global health organizations such as the WHO, UNICEF, and the Global Polio Eradication Initiative continue to work towards the goal of polio eradication. This includes surveillance to detect and respond to polio outbreaks, strengthening routine immunization programs, and addressing barriers to vaccination access.

Overall, polio remains a significant public health concern in some parts of the world, but with continued vaccination efforts and comprehensive disease control strategies, the goal of global polio eradication is within reach.

More Informations

Poliomyelitis, often shortened to polio, is a viral infectious disease caused by the poliovirus, which is a member of the genus Enterovirus in the Picornaviridae family. The disease primarily affects young children, but it can occur at any age. Polio is highly contagious and spreads through the fecal-oral route, meaning it is transmitted through contact with fecal matter containing the virus or through respiratory droplets from an infected person.

The poliovirus has three serotypes: type 1, type 2, and type 3. While all three serotypes can cause polio, type 1 historically accounts for the majority of cases. The virus enters the body through the mouth, infects the gastrointestinal tract, and then spreads to the bloodstream. From there, it can invade the nervous system, leading to neurological complications such as paralysis.

The vast majority of poliovirus infections are asymptomatic or cause only mild symptoms, such as fever, sore throat, headache, and gastrointestinal disturbances. This form of the disease is known as subclinical or asymptomatic polio. However, in a small percentage of cases, the virus invades the central nervous system, causing more severe symptoms.

There are three main forms of polio:

  1. Abortive polio: This is the mildest form of the disease, characterized by flu-like symptoms such as fever, sore throat, headache, vomiting, and fatigue. These symptoms typically last for one to two weeks and then resolve completely.

  2. Non-paralytic polio (aseptic meningitis): In non-paralytic polio, the virus invades the central nervous system, causing symptoms such as fever, headache, stiff neck, muscle pain, and weakness. While paralysis does not occur, patients may experience significant discomfort and recovery may take several weeks.

  3. Paralytic polio: This is the most severe form of the disease, occurring in approximately 1% of poliovirus infections. Paralytic polio is characterized by muscle weakness or paralysis, typically affecting the legs but sometimes involving the muscles of the arms, neck, or diaphragm. Paralysis can be temporary or permanent, depending on the extent of nerve damage.

The diagnosis of polio is based on clinical symptoms, physical examination findings, and laboratory tests. Laboratory tests, such as viral culture or polymerase chain reaction (PCR), can confirm the presence of the poliovirus in samples of stool, throat secretions, or cerebrospinal fluid.

There is no specific treatment for polio, as antibiotics are ineffective against viral infections. However, supportive care is essential to manage symptoms and prevent complications. This may include rest, pain relief medications, physical therapy, and assistive devices such as braces or wheelchairs for patients with paralysis. In severe cases, respiratory support may be necessary for patients with paralysis of the respiratory muscles.

Prevention of polio is primarily achieved through vaccination. The two main types of polio vaccines are the inactivated polio vaccine (IPV) and the oral polio vaccine (OPV). IPV is administered as an injection and contains killed poliovirus strains, providing immunity without the risk of vaccine-associated paralytic polio. OPV is administered orally and contains live, attenuated poliovirus strains, which can induce both mucosal and systemic immune responses. Mass vaccination campaigns, routine immunization programs, and surveillance efforts have been instrumental in reducing the global burden of polio.

Despite significant progress in polio eradication efforts, challenges remain, particularly in regions with weak health infrastructure, conflict, and vaccine hesitancy. To address these challenges, global health organizations such as the World Health Organization (WHO), UNICEF, and the Global Polio Eradication Initiative (GPEI) continue to work towards the goal of polio eradication through comprehensive vaccination campaigns, surveillance activities, and community engagement efforts.

In 1988, the WHO launched the Global Polio Eradication Initiative (GPEI) with the goal of eliminating polio worldwide. Since then, tremendous progress has been made, with global polio cases decreasing by over 99%. However, polio remains endemic in Afghanistan and Pakistan, and outbreaks continue to occur in other countries due to gaps in vaccination coverage and challenges in reaching vulnerable populations.

Overall, polio remains a significant public health concern in some parts of the world, but with continued vaccination efforts, surveillance activities, and comprehensive disease control strategies, the goal of global polio eradication is achievable.

Back to top button